news & events
portfolio news
06.08.18
Sanifit announces completion of enrollment in CaLIPSO – its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis
25.07.18
Aura Biosciences Presents Interim Phase 1b/2 Data at the American Society of Retina Specialists (ASRS) Annual Meeting
10.07.18
CorWave’s next-generation LVAD, Neptune, receives funding
27.06.18
Leading Prenatal App BabyscriptsTM Announces Acquisition of iBirthTM
27.06.18
BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
17.06.18
Aura Biosciences Announces Update of Clinical Safety and Efficacy Data on Lead Candidate AU-011 for Choroidal Melanoma
12.06.18
Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board
10.05.18
BioClin Therapeutics, Inc.,Completes $50 Million Series B Financing with Addition of New Investors
03.04.18
CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support
16.03.18
Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease
